Dynamic Equivalent Body Load Estimator
By dynamically estimating the equivalent amount of exogenous drugs in vivo, the problem of difficulty in real-time monitoring of drug absorption and distribution status in the prior art is solved, and more accurate and effective drug management in diabetes management is achieved.
Patent Information
- Application Number
- CN202080054094.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2019-06-19
- Filing Date
- 2020-06-19
- Publication Date
- 2025-03-28
- Estimated Expiration
- 2040-06-19
AI Technical Summary
It is difficult to accurately determine the absorption and distribution status of exogenous drugs in the body in real time, especially in diabetes management, and the concentration or quality of drugs is difficult to monitor in real time.
An adaptive body load estimation system is provided, which is used for decision support and artificial pancreatic algorithms in diabetes management software by dynamically estimating the equivalent amount of exogenous drugs in vivo and estimating based on prediction of glucose time series data.
Real-time dynamic estimation of exogenous drugs (such as insulin and carbohydrates) is achieved, which improves the accuracy and effectiveness of diabetes management and can dynamically adapt to individual metabolic changes.